Company Description
BBI (NASDAQ: BBI) is a publicly traded biological product (except diagnostic) manufacturing company in the Manufacturing sector. The company has a market capitalization of $6.8M.
BBI stock has gained 186.6% over the past year.
This page provides a comprehensive overview of BBI stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
BBI (BBI) stock. Over the past 12 months, the stock has gained 186.6%. At a market capitalization of $6.8M, BBI is classified as a micro-cap stock.
Latest News
BBI has 10 recent news articles. Key topics include earnings, clinical trial, management. View all BBI news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
BBI Company Profile & Sector Positioning
BBI (BBI) operates in the Biological Product (except Diagnostic) Manufacturing industry within the broader Manufacturing sector and is listed on the NASDAQ.